| abstract |
The present invention relates to compounds of the general formula (I): B-(CH--R1)n--C(=X2)-D and pharmaceutically acceptable salts thereof including steroisomers, to the use of the compounds for the treatment of impaired glucose tolerance, glucosuria, hyperlipidaemia, metabolic acidosis, diabetes mellitus, diabetic neuropathy and nephropathy and of sequelae caused by diabetes mellitus in mammals. |